Named company: BRAINMD
It was discovered that bottles of Brain and Memory Power Boost was filled with multi vitamin-mineral product - NeuroVite Plus
Named company: Baker's Corner Bakery
Butter and buttermilk declared in the ingredients statement but the Contains statement does not declare milk.
Named company: Lysulin, Inc.
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your “Lysulin ® Weight Loss Shake,” “Lysulin…
Named company: Aceva, LLC
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your Sugar Balance product fails to bear…
Named company: Ar-Rahman Pharm LLC
the Food and Drug Administration (FDA) reviewed your website at [see original source] in August 2021 and has determined that you take orders there for your Diabetes Support product. In addition, FDA reviewed…
Named company: Radhanite, LLC d/b/a Curalife Ltd
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, CuraLin, fails to bear adequate directions for…
Named company: McDaniel Water, LLC
Food and Drug Administration (FDA) reviewed your product labeling and your website at the Internet address www.mcdanielwater.com and has observed that you take orders there for the product “Black Indian…
Named company: Pharmaganics LLC
Curcumin treatment appeared to support healthy function of β-cells, the insulin producing cells of the pancreas.” • “Magnesium [ingredient in product]...Research shows that a 100 mg/day increase in magnesium…
Named company: Holistic Healer & Wellness Center, Inc.
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Diabalance Diabetes Supplement fails to bear…
Named company: Nuturna International LLC
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, your “Diabetic Support Formula” product fails…
These results describe the included collection. Sources and coverage.